Literature DB >> 10489266

Fasciolicides: efficacy, actions, resistance and its management.

I Fairweather1, J C Boray.   

Abstract

The modes of action of fasciolicides are described. Closantel and other salicylanilides interfere with energy metabolism by uncoupling oxidative phosphorylation in the fluke. Other fasciolicides are believed to have a metabolic action-halogenated phenols (via uncoupling) and clorsulon (via inhibition of glycolysis)-but direct evidence is lacking. Benzimidazoles (in particular, triclabendazole) bind to fluke tubulin and disrupt microtubule-based processes. Diamphenethide inhibits protein synthesis in the fluke. Other potential drug actions may contribute to overall drug efficacy. In particular, a number of fasciolicides-salicylanilides, phenols, diamphenethide-induce a rapid paralysis of the fluke, so their action may have a neuromuscular basis, although the actions remain ill-defined. Resistance to salicylanilides and triclabendazole has been detected in the field, although drug resistance does not appear to be a major problem yet. Strategies to minimize the development of resistance include the use of synergistic drug combinations, together with the design of integrated management programmes and the search for alternatives to drugs, in particular, vaccines. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489266     DOI: 10.1053/tvjl.1999.0377

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  56 in total

1.  Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes.

Authors:  M Meaney; I Fairweather; G P Brennan; L S L McDowell; A B Forbes
Journal:  Parasitol Res       Date:  2003-08-22       Impact factor: 2.289

2.  Triclabendazole protects yeast and mammalian cells from oxidative stress: identification of a potential neuroprotective compound.

Authors:  Yong Joo Lee; Elodie Burlet; Shaoxiao Wang; Baoshan Xu; Shile Huang; Floyd J Galiano; Stephan N Witt
Journal:  Biochem Biophys Res Commun       Date:  2011-09-16       Impact factor: 3.575

3.  Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).

Authors:  B McKinstry; G P Brennan; L Halferty; A B Forbes; I Fairweather
Journal:  Parasitol Res       Date:  2007-06-08       Impact factor: 2.289

4.  Expression of ATP-binding cassette multidrug transporters in the giant liver fluke Fasciola gigantica and their possible involvement in the transport of bile salts and anthelmintics.

Authors:  Supeecha Kumkate; Supatra Chunchob; Tavan Janvilisri
Journal:  Mol Cell Biochem       Date:  2008-06-10       Impact factor: 3.396

5.  In vitro ovicidal activity of Peganum harmala seeds extract on the eggs of Fasciola hepatica.

Authors:  Mohammad Moazeni; Zahra Sadat Saadaty Ardakani; Mohammad Jamal Saharkhiz; Jafar Jalaei; Ali Asghar Khademolhoseini; Shahab Shams Esfand Abad; Amir Mootabi Alavi
Journal:  J Parasit Dis       Date:  2016-08-29

6.  Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha.

Authors:  Maeve McConville; Robert E B Hanna; Gerard P Brennan; Maurice McCoy; Hillary W J Edgar; Shirley McConnell; Rafael Castillo; Alicia Hernández-Campos; Ian Fairweather
Journal:  Parasitol Res       Date:  2009-11-18       Impact factor: 2.289

7.  A dual anthelmintic treatment strategic scheme for the control of fasciolosis in dairy sheep farms.

Authors:  Giuseppe Cringoli; Laura Rinaldi; Vincenzo Veneziano; Claudio Genchi
Journal:  Parasitol Res       Date:  2006-11       Impact factor: 2.289

8.  In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis.

Authors:  David Richter; Joachim Richter; Beate Grüner; Kathrin Kranz; Juliane Franz; Peter Kern
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

9.  Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.

Authors:  Maha-Hamadien Abdulla; Debbie S Ruelas; Brian Wolff; June Snedecor; Kee-Chong Lim; Fengyun Xu; Adam R Renslo; Janice Williams; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

10.  Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.

Authors:  Aruna D Balgi; Bruno D Fonseca; Elizabeth Donohue; Trevor C F Tsang; Patrick Lajoie; Christopher G Proud; Ivan R Nabi; Michel Roberge
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.